Legend Biotech and Johnson & Johnson announced their collaboration on CARVYKTI, while Legend Biotech also utilized LinkedIn for professional presence.
5 reports, 4 independent
Updated Sep 3
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 5
- Developments
- 3
- Repetition
- 40%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Legend Biotech and Johnson & Johnson announced their collaboration on CARVYKTI, while Legend Biotech also utilized LinkedIn for professional presence.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Legend Biotech and Johnson & Johnson are manufacturing their drug Carvykti at a facility located in Raritan, New Jersey.1 source
Legend Biotech develops CARVYKTI with Johnson & Johnson and uses LinkedIn for professional presence.1 source
The collaboration between Legend Biotech and J&J for Carvykti is generating optimism.1 source
Keep exploring
The entities involved
-
Legend Biotech
Biotech company
Nothing else this week.
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
LinkedIn
American social networking website for people in professional occupations
Related events
- Legend Biotech and BioTech, both healthcare companies, are currently competing for investment.
- Students are using LinkedIn for professional networking skills, with platforms like rsvp also facilitating networking.
- Sto uses LinkedIn for corporate communication.
- Agios Pharmaceuticals followed another company on LinkedIn on October 8, 2026.
Coverage
Newest first; wire copies grouped- biopharmadive.com
- fool.com
- GlobeNewswireLegend Biotech to Host Investor Conference Call on Second Quarter 2025 Results SOMERSET, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global l
- ZacksLegend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains? Legend Biotech Corporation Sponsored ADR (LEGN) shares soared 6% in the last trading session to close at $42.13. The move wa